ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Regnum Corporation (EM)

Regnum Corporation (EM) (RGMP)

0,000001
0,00
(0,00%)
Geschlossen 09 Juni 10:00PM

Regnum Corporation (EM) (RGMP) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
0,000001
( - )
Gebot
0,00
Fragen
0,00
Volumen
-
0,00 Tagesbereich 0,00
0,000001 52-Wochen-Bereich 0,000001
Marktkapitalisierung
Handelsende
0,000001
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
US$ 0
Ausgegebene Aktien
22.950.000
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-0
Gewinn pro Aktie (EPS)
-0,03
Erlöse (LTM)
-
Nettogewinn (LTM)
-693,71k

Über Regnum Corporation (EM)

Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody C—C chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells. The company was incorpo... Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody C—C chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells. The company was incorporated in 2016 and is based in New York, New York. Mehr anzeigen

Sektor
Media
Branche
Traditional Media
Hauptsitz
New York, United States
Gegründet
2026
Regnum Corporation (EM) is listed in the Media sector of the OTC Markets with ticker RGMP. The last closing price for Regnum (EM) was US$0,00. Over the last year, Regnum (EM) shares have traded in a share price range of US$ 0,000001 to US$ 0,000001.

Regnum (EM) currently has 22.950.000 shares in issue. The market capitalisation of Regnum (EM) is US$22,95 . Regnum (EM) has a price to earnings ratio (PE ratio) of -0.00.

RGMP Neueste Nachrichten

Keine Nachrichten vorhanden.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
12001.0E-61.0E-61.0E-600CS
26001.0E-61.0E-61.0E-600CS
52001.0E-61.0E-61.0E-600CS
156-0.149999-99.99933333330.150.4991.0E-667900.10748744CS
260-0.609989-99.99983606290.609991.431.0E-692880.40937888CS

RGMP - Frequently Asked Questions (FAQ)

What is the current Regnum Corporation (EM) share price?
The current share price of Regnum Corporation (EM) is US$ 0,000001
How many Regnum Corporation (EM) shares are in issue?
Regnum Corporation (EM) has 22.950.000 shares in issue
What is the market cap of Regnum Corporation (EM)?
The market capitalisation of Regnum Corporation (EM) is USD 22,95
What is the 1 year trading range for Regnum Corporation (EM) share price?
Regnum Corporation (EM) has traded in the range of US$ 0,000001 to US$ 0,000001 during the past year
What is the PE ratio of Regnum Corporation (EM)?
The price to earnings ratio of Regnum Corporation (EM) is -0
What is the registered address of Regnum Corporation (EM)?
The registered address for Regnum Corporation (EM) is 600 Third Avenue, New York, New York, 10016
Which industry sector does Regnum Corporation (EM) operate in?
Regnum Corporation (EM) operates in the Traditional Media sector

RGMP Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen